The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression

Publication date: Available online 1 July 2020Source: Journal of EthnopharmacologyAuthor(s): Huan Zhou, Li-xiang Fu, Li Li, Yan-yan Chen, Hong-qing Zhu, Jin-ling Zhou, Mei-xian Lv, Ri-zhi Gan, Xuan-xuan Zhang, Gang Liang
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research